GlassScriptPhysician profile
Sheel Yeshwant Tolia
NPI 1114152675
$3,823.48
in general payments reported to CMS, 2019-2025
19 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $95.35 · 2021: $172 · 2022: $207 · 2023: $908 · 2024: $2,053 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,940 · Travel and Lodging: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,940.35 |
| Travel and Lodging | $1,191.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,118.84 | 2023-2024 | Watchman Access System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $445.44 | 2019-2025 | Aveir, Fortify Assura, Gallant |
| Novartis Pharmaceuticals Corporation | $316.85 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.29 | 2024-2025 | Lifevest |
| Irhythm Technologies, INC. | $121.89 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| E.R. Squibb & Sons, L.L.C. | $121.63 | 2020-2022 | |
| Biosense Webster, INC. | $113.75 | 2023 | Qdot Micro Catheter, Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.06 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $54.56 | 2019-2021 | |
| Amgen INC. | $51.80 | 2019-2023 | Repatha |
| Amarin Pharma, INC. | $34.38 | 2021 | |
| Novo Nordisk INC | $32.60 | 2022-2023 | Ozempic |
| Bardy Diagnostics, INC. | $26.40 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $20.99 | 2020 | |
| Kestra Medical Technology Services, INC. | $19.31 | 2025 | Assure Wcd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.89 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $17.42 | 2021 | |
| Esperion Therapeutics, INC. | $14.71 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheel Tolia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.